Ensuring diversity in clinical trials is a growing concern in the life sciences space. According to the FDA's Drug Trials Snapshot, about 75% of participants in studies for new molecular entities and therapeutic biologics approved in 2020 were white.
Meanwhile a study published early last year in JAMA Network Open found 58% of U.S.-based vaccine trials reported race, and only 34% recorded...
A new report from Research2Guidance discusses the rise in digital decentralised clinical trial (DDCT) technologies since the COVID-19 pandemic.
Digital solutions for decentralised clinical trials allow some or all clinical trial activities to be conducted virtually rather than in person. This includes technology such as wearables to continuously collect patient data, telemedicine to deliver...
For decades, the medical and life science communities have discussed boosting diversity in clinical trials. However, research today is still coming up short. According to a 2019 JAMA study, out of 230 trials leading to FDA oncology drug approvals over the past decade, race was only reported by 63%.
“We would want representation of trial participants to reflect the population of the disease that'...
The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining traction ever since. But, like so many other remote tools, it's been greatly accelerated by the COVID-19 pandemic.
On today's HIMSSCast, host Jonah Comstock and MobiHealthNews Managing Editor Laura...
Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective.
Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
Oxford-based biotech company, Theolytics has announced the closing of a US $6.8 million (£5 million) Series A round.
The round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI).
The financing will be used to progress the company’s pipeline of candidates towards human clinical trials.
WHY IT MATTERS
Theolytics will...
A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by Ben-Gurion University of the Negev (BGU).
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors including...
UK-based independent SMO, Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor.
WHY IT MATTERS
Panthera is looking to extend its UK site network by opening a new clinic in Glasgow and expanding existing locations to service higher patient volumes and take forward alliance partnerships across Europe.
The Series A funding will also ensure...
UK-based data capture software company, uMotif, has raised £5 million in a Series A investment round led by existing investor AlbionVC.
The funding will accelerate uMotif’s growth and enable further development of its patient-centric and decentralised approach to clinical studies and enable expansion into new study types and more high-demand territories.
WHY IT MATTERS
Life sciences companies...
Historically, women have been underrepresented in clinical trials, however, that paradigm is changing. This shift is mainly due to policy changes in the last three decades, but today many innovators are also seeing a role for tech to play in closing this gap.
This morning MobiHealthNews sat down with a panel at Women of Wearables’ FemTech Forum to moderate a discussion about the gender gap in...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
.jpg?itok=J3u6OpaH "Medical consultation in office")
.jpg?itok=fshRV9W- "The company will expand its oncolytic viral therapy platform to combat cancer.")
.jpg?itok=MZ_RxCEv "The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.")
